PIK3CA and neoplasm: A remarkable 100% efficiency has been seen when applying 4NQO to XPA−/−; p53+/− mice, which develop tumours in 25 weeks, compared with 50 weeks without the carcinogen [81] or to PIK3CA-GEMM mice.